Trauma Lecture - June 2014 - Hyperfibrinolysis, Physiologic Fibrinolysis, and Fibrinolysis Shutdown: The Spectrum of Postinjury Fibrinolysis and Relevance to Antifibrinolytic Therapy

Please join Denver Health for a unique continuing education opportunity on post-injury fibrinolysis.  Dr. Ernest E. “Gene” Moore will begin with an analysis of the CRASH-2 trial plus emerging literature on antifibrinolytics in the injured patient, including Tranexamic Acid (TXA).  Dr. Hunter Moore will then present his clinical research findings that recently won the American College of Surgeons Committee on Trauma resident competition on The Spectrum of Postinjury Fibrinolysis and Relevance to Antifibrinolytic Therapy.  Dr. Christopher Colwell will be moderating this event and asking questions specific to use of TXA in the prehospital and emergency department setting.  Thromboelastography (TEG) in trauma will also be discussed. 

 Live audience participation at Denver Health is by invitation-only.  Webinar participation is open to all, but requires registration.  Questions from webinar participants can be submitted online during the event.  Physician and EMS continuing education hours will be provided.

 Online via Live Webinar | Free

Presented By

Gene Moore, MD
Trauma Surgeon, Denver Health
Editor, Journal of Trauma and Acute Care Surgery

Hunter Moore, MD
Trauma and Acute Care Surgeon, Denver Health

Chris Colwell, MD
Director of Emergency Medicine, Denver Health

CVENT Register 2014

  • When

  • Wednesday, June 25, 2014
    11:00 AM - 12:00 PM
    Mountain Time

  • Where

  • Available Online

CNE/CME Credit

Contact the Event Organizer

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!